1. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma;Guest;Cancer Res,2014
2. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma;Bridgewater;J Hepatol,2014
3. American Cancer Society. Survival Rates for Bile Duct Cancer Where do these numbers come from? 2020. https://www.cancer.org/cancer/bile-duct-cancer/detection-diagnosis-staging/survival-by-stage.html.
4. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Banales;Nat Rev Gastroenterol Hepatol,2020
5. Administration USF and D. FDA grants accelerated approval to pemigatinib for cholangiocarcinoma with an FGFR2 rearrangement or fusion. 2020. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-pemigatinib-cholangiocarcinoma-fgfr2-rearrangement-or-fusion.